Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Hormonal Contraception Market Growth 2022-2028

  • LP 4830123
  • 108 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Hormonal Contraception will have significant change from previous year. According to our (LP Information) latest study, the global Hormonal Contraception market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Hormonal Contraception market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Hormonal Contraception market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Hormonal Contraception market, reaching US$ million by the year 2028. As for the Europe Hormonal Contraception landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Hormonal Contraception players cover Bayer AG, Merck & Co., Inc., Pfizer, Inc., and Agile Therapeutics, Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Hormonal Contraception market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

by Hormone

Androgens

Estrogens

Progestrogens

Antiandrogens

Gonadotropins

by Method

Combined Oral

Oral Pill

Implanted

Injected

Intrauterine

Transdermal Patch

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Clinics

Gynaecology Centers

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Bayer AG

Merck & Co., Inc.

Pfizer, Inc.

Agile Therapeutics, Inc.

Teva Pharmaceutical Industries Ltd.

Amgen

Cipla Ltd.

Glenmark Pharmaceuticals Inc.

Lupin Limited(Lupin Pharmaceuticals, Inc.)

Novartis AG

Mylan N.V.

Johnson & Johnson

Ansell LTD

Mayer Laboratories, Inc.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Hormonal Contraception Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Hormonal Contraception by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Hormonal Contraception by Country/Region, 2017, 2022 & 2028

2.2 Hormonal Contraception Segment by Type

2.2.1 Androgens

2.2.2 Estrogens

2.2.3 Progestrogens

2.2.4 Antiandrogens

2.2.5 Gonadotropins

2.3 Hormonal Contraception Sales by Type

2.3.1 Global Hormonal Contraception Sales Market Share by Type (2017-2022)

2.3.2 Global Hormonal Contraception Revenue and Market Share by Type (2017-2022)

2.3.3 Global Hormonal Contraception Sale Price by Type (2017-2022)

2.4 Hormonal Contraception Segment by Application

2.4.1 Hospital

2.4.2 Clinics

2.4.3 Gynaecology Centers

2.4.4 Others

2.5 Hormonal Contraception Sales by Application

2.5.1 Global Hormonal Contraception Sale Market Share by Application (2017-2022)

2.5.2 Global Hormonal Contraception Revenue and Market Share by Application (2017-2022)

2.5.3 Global Hormonal Contraception Sale Price by Application (2017-2022)

3 Global Hormonal Contraception by Company

3.1 Global Hormonal Contraception Breakdown Data by Company

3.1.1 Global Hormonal Contraception Annual Sales by Company (2020-2022)

3.1.2 Global Hormonal Contraception Sales Market Share by Company (2020-2022)

3.2 Global Hormonal Contraception Annual Revenue by Company (2020-2022)

3.2.1 Global Hormonal Contraception Revenue by Company (2020-2022)

3.2.2 Global Hormonal Contraception Revenue Market Share by Company (2020-2022)

3.3 Global Hormonal Contraception Sale Price by Company

3.4 Key Manufacturers Hormonal Contraception Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Hormonal Contraception Product Location Distribution

3.4.2 Players Hormonal Contraception Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Hormonal Contraception by Geographic Region

4.1 World Historic Hormonal Contraception Market Size by Geographic Region (2017-2022)

4.1.1 Global Hormonal Contraception Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Hormonal Contraception Annual Revenue by Geographic Region

4.2 World Historic Hormonal Contraception Market Size by Country/Region (2017-2022)

4.2.1 Global Hormonal Contraception Annual Sales by Country/Region (2017-2022)

4.2.2 Global Hormonal Contraception Annual Revenue by Country/Region

4.3 Americas Hormonal Contraception Sales Growth

4.4 APAC Hormonal Contraception Sales Growth

4.5 Europe Hormonal Contraception Sales Growth

4.6 Middle East & Africa Hormonal Contraception Sales Growth

5 Americas

5.1 Americas Hormonal Contraception Sales by Country

5.1.1 Americas Hormonal Contraception Sales by Country (2017-2022)

5.1.2 Americas Hormonal Contraception Revenue by Country (2017-2022)

5.2 Americas Hormonal Contraception Sales by Type

5.3 Americas Hormonal Contraception Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Hormonal Contraception Sales by Region

6.1.1 APAC Hormonal Contraception Sales by Region (2017-2022)

6.1.2 APAC Hormonal Contraception Revenue by Region (2017-2022)

6.2 APAC Hormonal Contraception Sales by Type

6.3 APAC Hormonal Contraception Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Hormonal Contraception by Country

7.1.1 Europe Hormonal Contraception Sales by Country (2017-2022)

7.1.2 Europe Hormonal Contraception Revenue by Country (2017-2022)

7.2 Europe Hormonal Contraception Sales by Type

7.3 Europe Hormonal Contraception Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Hormonal Contraception by Country

8.1.1 Middle East & Africa Hormonal Contraception Sales by Country (2017-2022)

8.1.2 Middle East & Africa Hormonal Contraception Revenue by Country (2017-2022)

8.2 Middle East & Africa Hormonal Contraception Sales by Type

8.3 Middle East & Africa Hormonal Contraception Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Hormonal Contraception

10.3 Manufacturing Process Analysis of Hormonal Contraception

10.4 Industry Chain Structure of Hormonal Contraception

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Hormonal Contraception Distributors

11.3 Hormonal Contraception Customer

12 World Forecast Review for Hormonal Contraception by Geographic Region

12.1 Global Hormonal Contraception Market Size Forecast by Region

12.1.1 Global Hormonal Contraception Forecast by Region (2023-2028)

12.1.2 Global Hormonal Contraception Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Hormonal Contraception Forecast by Type

12.7 Global Hormonal Contraception Forecast by Application

13 Key Players Analysis

13.1 Bayer AG

13.1.1 Bayer AG Company Information

13.1.2 Bayer AG Hormonal Contraception Product Offered

13.1.3 Bayer AG Hormonal Contraception Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bayer AG Main Business Overview

13.1.5 Bayer AG Latest Developments

13.2 Merck & Co., Inc.

13.2.1 Merck & Co., Inc. Company Information

13.2.2 Merck & Co., Inc. Hormonal Contraception Product Offered

13.2.3 Merck & Co., Inc. Hormonal Contraception Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck & Co., Inc. Main Business Overview

13.2.5 Merck & Co., Inc. Latest Developments

13.3 Pfizer, Inc.

13.3.1 Pfizer, Inc. Company Information

13.3.2 Pfizer, Inc. Hormonal Contraception Product Offered

13.3.3 Pfizer, Inc. Hormonal Contraception Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pfizer, Inc. Main Business Overview

13.3.5 Pfizer, Inc. Latest Developments

13.4 Agile Therapeutics, Inc.

13.4.1 Agile Therapeutics, Inc. Company Information

13.4.2 Agile Therapeutics, Inc. Hormonal Contraception Product Offered

13.4.3 Agile Therapeutics, Inc. Hormonal Contraception Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Agile Therapeutics, Inc. Main Business Overview

13.4.5 Agile Therapeutics, Inc. Latest Developments

13.5 Teva Pharmaceutical Industries Ltd.

13.5.1 Teva Pharmaceutical Industries Ltd. Company Information

13.5.2 Teva Pharmaceutical Industries Ltd. Hormonal Contraception Product Offered

13.5.3 Teva Pharmaceutical Industries Ltd. Hormonal Contraception Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Teva Pharmaceutical Industries Ltd. Main Business Overview

13.5.5 Teva Pharmaceutical Industries Ltd. Latest Developments

13.6 Amgen

13.6.1 Amgen Company Information

13.6.2 Amgen Hormonal Contraception Product Offered

13.6.3 Amgen Hormonal Contraception Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Amgen Main Business Overview

13.6.5 Amgen Latest Developments

13.7 Cipla Ltd.

13.7.1 Cipla Ltd. Company Information

13.7.2 Cipla Ltd. Hormonal Contraception Product Offered

13.7.3 Cipla Ltd. Hormonal Contraception Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Cipla Ltd. Main Business Overview

13.7.5 Cipla Ltd. Latest Developments

13.8 Glenmark Pharmaceuticals Inc.

13.8.1 Glenmark Pharmaceuticals Inc. Company Information

13.8.2 Glenmark Pharmaceuticals Inc. Hormonal Contraception Product Offered

13.8.3 Glenmark Pharmaceuticals Inc. Hormonal Contraception Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Glenmark Pharmaceuticals Inc. Main Business Overview

13.8.5 Glenmark Pharmaceuticals Inc. Latest Developments

13.9 Lupin Limited(Lupin Pharmaceuticals, Inc.)

13.9.1 Lupin Limited(Lupin Pharmaceuticals, Inc.) Company Information

13.9.2 Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Product Offered

13.9.3 Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Lupin Limited(Lupin Pharmaceuticals, Inc.) Main Business Overview

13.9.5 Lupin Limited(Lupin Pharmaceuticals, Inc.) Latest Developments

13.10 Novartis AG

13.10.1 Novartis AG Company Information

13.10.2 Novartis AG Hormonal Contraception Product Offered

13.10.3 Novartis AG Hormonal Contraception Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Novartis AG Main Business Overview

13.10.5 Novartis AG Latest Developments

13.11 Mylan N.V.

13.11.1 Mylan N.V. Company Information

13.11.2 Mylan N.V. Hormonal Contraception Product Offered

13.11.3 Mylan N.V. Hormonal Contraception Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Mylan N.V. Main Business Overview

13.11.5 Mylan N.V. Latest Developments

13.12 Johnson & Johnson

13.12.1 Johnson & Johnson Company Information

13.12.2 Johnson & Johnson Hormonal Contraception Product Offered

13.12.3 Johnson & Johnson Hormonal Contraception Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Johnson & Johnson Main Business Overview

13.12.5 Johnson & Johnson Latest Developments

13.13 Ansell LTD

13.13.1 Ansell LTD Company Information

13.13.2 Ansell LTD Hormonal Contraception Product Offered

13.13.3 Ansell LTD Hormonal Contraception Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Ansell LTD Main Business Overview

13.13.5 Ansell LTD Latest Developments

13.14 Mayer Laboratories, Inc.

13.14.1 Mayer Laboratories, Inc. Company Information

13.14.2 Mayer Laboratories, Inc. Hormonal Contraception Product Offered

13.14.3 Mayer Laboratories, Inc. Hormonal Contraception Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Mayer Laboratories, Inc. Main Business Overview

13.14.5 Mayer Laboratories, Inc. Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Hormonal Contraception Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Hormonal Contraception Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Androgens

Table 4. Major Players of Estrogens

Table 5. Major Players of Progestrogens

Table 6. Major Players of Antiandrogens

Table 7. Major Players of Gonadotropins

Table 8. Global Hormonal Contraception Sales by Type (2017-2022) & (K Units)

Table 9. Global Hormonal Contraception Sales Market Share by Type (2017-2022)

Table 10. Global Hormonal Contraception Revenue by Type (2017-2022) & ($ million)

Table 11. Global Hormonal Contraception Revenue Market Share by Type (2017-2022)

Table 12. Global Hormonal Contraception Sale Price by Type (2017-2022) & (US$/Unit)

Table 13. Global Hormonal Contraception Sales by Application (2017-2022) & (K Units)

Table 14. Global Hormonal Contraception Sales Market Share by Application (2017-2022)

Table 15. Global Hormonal Contraception Revenue by Application (2017-2022)

Table 16. Global Hormonal Contraception Revenue Market Share by Application (2017-2022)

Table 17. Global Hormonal Contraception Sale Price by Application (2017-2022) & (US$/Unit)

Table 18. Global Hormonal Contraception Sales by Company (2020-2022) & (K Units)

Table 19. Global Hormonal Contraception Sales Market Share by Company (2020-2022)

Table 20. Global Hormonal Contraception Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Hormonal Contraception Revenue Market Share by Company (2020-2022)

Table 22. Global Hormonal Contraception Sale Price by Company (2020-2022) & (US$/Unit)

Table 23. Key Manufacturers Hormonal Contraception Producing Area Distribution and Sales Area

Table 24. Players Hormonal Contraception Products Offered

Table 25. Hormonal Contraception Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Hormonal Contraception Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Hormonal Contraception Sales Market Share Geographic Region (2017-2022)

Table 30. Global Hormonal Contraception Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Hormonal Contraception Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Hormonal Contraception Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Hormonal Contraception Sales Market Share by Country/Region (2017-2022)

Table 34. Global Hormonal Contraception Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Hormonal Contraception Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Hormonal Contraception Sales by Country (2017-2022) & (K Units)

Table 37. Americas Hormonal Contraception Sales Market Share by Country (2017-2022)

Table 38. Americas Hormonal Contraception Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Hormonal Contraception Revenue Market Share by Country (2017-2022)

Table 40. Americas Hormonal Contraception Sales by Type (2017-2022) & (K Units)

Table 41. Americas Hormonal Contraception Sales Market Share by Type (2017-2022)

Table 42. Americas Hormonal Contraception Sales by Application (2017-2022) & (K Units)

Table 43. Americas Hormonal Contraception Sales Market Share by Application (2017-2022)

Table 44. APAC Hormonal Contraception Sales by Region (2017-2022) & (K Units)

Table 45. APAC Hormonal Contraception Sales Market Share by Region (2017-2022)

Table 46. APAC Hormonal Contraception Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Hormonal Contraception Revenue Market Share by Region (2017-2022)

Table 48. APAC Hormonal Contraception Sales by Type (2017-2022) & (K Units)

Table 49. APAC Hormonal Contraception Sales Market Share by Type (2017-2022)

Table 50. APAC Hormonal Contraception Sales by Application (2017-2022) & (K Units)

Table 51. APAC Hormonal Contraception Sales Market Share by Application (2017-2022)

Table 52. Europe Hormonal Contraception Sales by Country (2017-2022) & (K Units)

Table 53. Europe Hormonal Contraception Sales Market Share by Country (2017-2022)

Table 54. Europe Hormonal Contraception Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Hormonal Contraception Revenue Market Share by Country (2017-2022)

Table 56. Europe Hormonal Contraception Sales by Type (2017-2022) & (K Units)

Table 57. Europe Hormonal Contraception Sales Market Share by Type (2017-2022)

Table 58. Europe Hormonal Contraception Sales by Application (2017-2022) & (K Units)

Table 59. Europe Hormonal Contraception Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Hormonal Contraception Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Hormonal Contraception Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Hormonal Contraception Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Hormonal Contraception Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Hormonal Contraception Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Hormonal Contraception Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Hormonal Contraception Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Hormonal Contraception Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Hormonal Contraception

Table 69. Key Market Challenges & Risks of Hormonal Contraception

Table 70. Key Industry Trends of Hormonal Contraception

Table 71. Hormonal Contraception Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Hormonal Contraception Distributors List

Table 74. Hormonal Contraception Customer List

Table 75. Global Hormonal Contraception Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Hormonal Contraception Sales Market Forecast by Region

Table 77. Global Hormonal Contraception Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Hormonal Contraception Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Hormonal Contraception Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Hormonal Contraception Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Hormonal Contraception Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Hormonal Contraception Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Hormonal Contraception Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Hormonal Contraception Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Hormonal Contraception Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Hormonal Contraception Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Hormonal Contraception Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Hormonal Contraception Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Hormonal Contraception Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Hormonal Contraception Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Hormonal Contraception Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Hormonal Contraception Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Hormonal Contraception Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Hormonal Contraception Revenue Market Share Forecast by Application (2023-2028)

Table 95. Bayer AG Basic Information, Hormonal Contraception Manufacturing Base, Sales Area and Its Competitors

Table 96. Bayer AG Hormonal Contraception Product Offered

Table 97. Bayer AG Hormonal Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 98. Bayer AG Main Business

Table 99. Bayer AG Latest Developments

Table 100. Merck & Co., Inc. Basic Information, Hormonal Contraception Manufacturing Base, Sales Area and Its Competitors

Table 101. Merck & Co., Inc. Hormonal Contraception Product Offered

Table 102. Merck & Co., Inc. Hormonal Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 103. Merck & Co., Inc. Main Business

Table 104. Merck & Co., Inc. Latest Developments

Table 105. Pfizer, Inc. Basic Information, Hormonal Contraception Manufacturing Base, Sales Area and Its Competitors

Table 106. Pfizer, Inc. Hormonal Contraception Product Offered

Table 107. Pfizer, Inc. Hormonal Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 108. Pfizer, Inc. Main Business

Table 109. Pfizer, Inc. Latest Developments

Table 110. Agile Therapeutics, Inc. Basic Information, Hormonal Contraception Manufacturing Base, Sales Area and Its Competitors

Table 111. Agile Therapeutics, Inc. Hormonal Contraception Product Offered

Table 112. Agile Therapeutics, Inc. Hormonal Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 113. Agile Therapeutics, Inc. Main Business

Table 114. Agile Therapeutics, Inc. Latest Developments

Table 115. Teva Pharmaceutical Industries Ltd. Basic Information, Hormonal Contraception Manufacturing Base, Sales Area and Its Competitors

Table 116. Teva Pharmaceutical Industries Ltd. Hormonal Contraception Product Offered

Table 117. Teva Pharmaceutical Industries Ltd. Hormonal Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 118. Teva Pharmaceutical Industries Ltd. Main Business

Table 119. Teva Pharmaceutical Industries Ltd. Latest Developments

Table 120. Amgen Basic Information, Hormonal Contraception Manufacturing Base, Sales Area and Its Competitors

Table 121. Amgen Hormonal Contraception Product Offered

Table 122. Amgen Hormonal Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 123. Amgen Main Business

Table 124. Amgen Latest Developments

Table 125. Cipla Ltd. Basic Information, Hormonal Contraception Manufacturing Base, Sales Area and Its Competitors

Table 126. Cipla Ltd. Hormonal Contraception Product Offered

Table 127. Cipla Ltd. Hormonal Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 128. Cipla Ltd. Main Business

Table 129. Cipla Ltd. Latest Developments

Table 130. Glenmark Pharmaceuticals Inc. Basic Information, Hormonal Contraception Manufacturing Base, Sales Area and Its Competitors

Table 131. Glenmark Pharmaceuticals Inc. Hormonal Contraception Product Offered

Table 132. Glenmark Pharmaceuticals Inc. Hormonal Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 133. Glenmark Pharmaceuticals Inc. Main Business

Table 134. Glenmark Pharmaceuticals Inc. Latest Developments

Table 135. Lupin Limited(Lupin Pharmaceuticals, Inc.) Basic Information, Hormonal Contraception Manufacturing Base, Sales Area and Its Competitors

Table 136. Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Product Offered

Table 137. Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 138. Lupin Limited(Lupin Pharmaceuticals, Inc.) Main Business

Table 139. Lupin Limited(Lupin Pharmaceuticals, Inc.) Latest Developments

Table 140. Novartis AG Basic Information, Hormonal Contraception Manufacturing Base, Sales Area and Its Competitors

Table 141. Novartis AG Hormonal Contraception Product Offered

Table 142. Novartis AG Hormonal Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 143. Novartis AG Main Business

Table 144. Novartis AG Latest Developments

Table 145. Mylan N.V. Basic Information, Hormonal Contraception Manufacturing Base, Sales Area and Its Competitors

Table 146. Mylan N.V. Hormonal Contraception Product Offered

Table 147. Mylan N.V. Hormonal Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 148. Mylan N.V. Main Business

Table 149. Mylan N.V. Latest Developments

Table 150. Johnson & Johnson Basic Information, Hormonal Contraception Manufacturing Base, Sales Area and Its Competitors

Table 151. Johnson & Johnson Hormonal Contraception Product Offered

Table 152. Johnson & Johnson Hormonal Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 153. Johnson & Johnson Main Business

Table 154. Johnson & Johnson Latest Developments

Table 155. Ansell LTD Basic Information, Hormonal Contraception Manufacturing Base, Sales Area and Its Competitors

Table 156. Ansell LTD Hormonal Contraception Product Offered

Table 157. Ansell LTD Hormonal Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 158. Ansell LTD Main Business

Table 159. Ansell LTD Latest Developments

Table 160. Mayer Laboratories, Inc. Basic Information, Hormonal Contraception Manufacturing Base, Sales Area and Its Competitors

Table 161. Mayer Laboratories, Inc. Hormonal Contraception Product Offered

Table 162. Mayer Laboratories, Inc. Hormonal Contraception Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 163. Mayer Laboratories, Inc. Main Business

Table 164. Mayer Laboratories, Inc. Latest Developments

List of Figures

Figure 1. Picture of Hormonal Contraception

Figure 2. Hormonal Contraception Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Hormonal Contraception Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Hormonal Contraception Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Hormonal Contraception Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Androgens

Figure 10. Product Picture of Estrogens

Figure 11. Product Picture of Progestrogens

Figure 12. Product Picture of Antiandrogens

Figure 13. Product Picture of Gonadotropins

Figure 14. Global Hormonal Contraception Sales Market Share by Type in 2021

Figure 15. Global Hormonal Contraception Revenue Market Share by Type (2017-2022)

Figure 16. Hormonal Contraception Consumed in Hospital

Figure 17. Global Hormonal Contraception Market: Hospital (2017-2022) & (K Units)

Figure 18. Hormonal Contraception Consumed in Clinics

Figure 19. Global Hormonal Contraception Market: Clinics (2017-2022) & (K Units)

Figure 20. Hormonal Contraception Consumed in Gynaecology Centers

Figure 21. Global Hormonal Contraception Market: Gynaecology Centers (2017-2022) & (K Units)

Figure 22. Hormonal Contraception Consumed in Others

Figure 23. Global Hormonal Contraception Market: Others (2017-2022) & (K Units)

Figure 24. Global Hormonal Contraception Sales Market Share by Application (2017-2022)

Figure 25. Global Hormonal Contraception Revenue Market Share by Application in 2021

Figure 26. Hormonal Contraception Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Hormonal Contraception Revenue Market Share by Company in 2021

Figure 28. Global Hormonal Contraception Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Hormonal Contraception Revenue Market Share by Geographic Region in 2021

Figure 30. Global Hormonal Contraception Sales Market Share by Region (2017-2022)

Figure 31. Global Hormonal Contraception Revenue Market Share by Country/Region in 2021

Figure 32. Americas Hormonal Contraception Sales 2017-2022 (K Units)

Figure 33. Americas Hormonal Contraception Revenue 2017-2022 ($ Millions)

Figure 34. APAC Hormonal Contraception Sales 2017-2022 (K Units)

Figure 35. APAC Hormonal Contraception Revenue 2017-2022 ($ Millions)

Figure 36. Europe Hormonal Contraception Sales 2017-2022 (K Units)

Figure 37. Europe Hormonal Contraception Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Hormonal Contraception Sales 2017-2022 (K Units)

Figure 39. Middle East & Africa Hormonal Contraception Revenue 2017-2022 ($ Millions)

Figure 40. Americas Hormonal Contraception Sales Market Share by Country in 2021

Figure 41. Americas Hormonal Contraception Revenue Market Share by Country in 2021

Figure 42. United States Hormonal Contraception Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Hormonal Contraception Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Hormonal Contraception Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Hormonal Contraception Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Hormonal Contraception Sales Market Share by Region in 2021

Figure 47. APAC Hormonal Contraception Revenue Market Share by Regions in 2021

Figure 48. China Hormonal Contraception Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Hormonal Contraception Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Hormonal Contraception Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Hormonal Contraception Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Hormonal Contraception Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Hormonal Contraception Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Hormonal Contraception Sales Market Share by Country in 2021

Figure 55. Europe Hormonal Contraception Revenue Market Share by Country in 2021

Figure 56. Germany Hormonal Contraception Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Hormonal Contraception Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Hormonal Contraception Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Hormonal Contraception Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Hormonal Contraception Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Hormonal Contraception Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Hormonal Contraception Revenue Market Share by Country in 2021

Figure 63. Egypt Hormonal Contraception Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Hormonal Contraception Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Hormonal Contraception Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Hormonal Contraception Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Hormonal Contraception Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Hormonal Contraception in 2021

Figure 69. Manufacturing Process Analysis of Hormonal Contraception

Figure 70. Industry Chain Structure of Hormonal Contraception

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390